Patrick M. Medley

I'll research this attorney before drafting. Let me run several searches.

Let me verify the specific tracked cases and confirm the PTAB authorship distinction.

Patrick M. Medley — Patent Litigation Practice Summary

Focus areas. Medley's tracked work clusters in two areas: (1) post-grant patent challenges in the pharmaceutical/chemical space, and (2) computer-implemented credentialing and payment technology. The Azurity matters concern methods and compositions for treating chemotherapy-induced nausea and vomiting, while the Cortex MCP/Visa dispute involves patents on a "file format and platform for storage and verification of credentials" (i.e., secure digital credential and payment verification, U.S. Patent Nos. 9,251,531; 9,954,854; 10,749,859; 11,329,973). His WSGR bio describes broader experience across software, networking, imaging, electronic devices, pharmaceuticals, and medical devices, and USPTO filing records show a substantial prosecution docket for genomics/life-sciences applicants (10x Genomics, Guardant Health, Ultima Genomics, Seer, Sanford Burnham Prebys, Cedars-Sinai) and medical-device maker Align Technology. No tracked case involves Wi-Fi or wireless standards.

Side preference. Mixed, but with a distinct emphasis on challenging patents rather than defending infringement claims. Three tracked appearances are on the plaintiff/petitioner side (Unified Patents, and Azurity twice) versus one on the defense side (Visa). Two of the "plaintiff" entries are IPR petitions rather than district court complaints: Unified Patents (a defensive aggregator) petitioning against Cortex MCP, and Azurity petitioning against Helsinn. Notably, the Visa defense and the Unified Patents challenge target the same patent family, consistent with a coordinated defense against Cortex MCP. Only one tracked matter is a defense of an operating company against an infringement claim.

Notable matters and PTAB/IPR experience. Medley appears regularly in PTAB proceedings, almost always as back-up counsel. He was on the WSGR team that secured institution of all five Azurity IPRs against Helsinn in November 2025 — a result WIPR highlighted given tightened institution rates. He is listed as back-up counsel on Visa's five IPR petitions against Cortex MCP (IPR2024-00486 through -00490), which produced four final written decisions in July 2025 with mixed outcomes and are now on appeal to the Federal Circuit; the district court has stayed and then extended the stay of the underlying N.D. Cal. case pending that appeal. He is also back-up counsel in Align Technology's IPR proceeding against ClearCorrect and appears in Azurity's IPR filings. Caution: several PTAB decisions attributed in secondary sources to "Medley, APJ" (e.g., Ford v. Paice, Allsteel v. DIRTT) are authored by an Administrative Patent Judge of that name and should not be attributed to this attorney.

Firm, bar, and education. He is in Wilson Sonsini Goodrich & Rosati's Seattle office; no prior law-firm history appears in the sources reviewed, and his pre-law career was as a physics researcher (postdoctoral fellow at Stanford; Ph.D. work at MIT). Note a source discrepancy: the firm website currently lists him as an associate, while the tracked appearance roles list him as of counsel — the firm bio appears potentially out of date. He is admitted to the State Bar of Washington and registered with the USPTO (Reg. No. 74,735). Education: J.D., University of Washington School of Law (2020, high honors); Ph.D., Physics, MIT (2010); B.A., Chemistry and Physics, Harvard (summa cum laude).